Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3

Published:2017-05 Issue:10 Volume:591 Page:1371-1382
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Lett

Author:

Singh Snahlata¹,Chouhan Surbhi¹,Mohammad Naoshad¹,Bhat Manoj Kumar¹

Affiliation:

1. National Centre for Cell Science; Pune India

Funder

National Centre for Cell Science (NCCS)

Department of Biotechnology , Ministry of Science and Technology

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Reference45 articles.

1. The hormone resistin links obesity to diabetes;Steppan;Nature,2001

2. Resistin, an adipokine with potent proinflammatory properties;Bokarewa;J Immunol,2005

3. Serum resistin, cardiovascular disease and all- cause mortality in patients with type 2 diabetes;Menzaghi;PLoS One,2012

4. Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters;Dalamaga;Clin Biochem,2013

5. Serum levels of adipokines resistin and leptin in patients with colon cancer;Sălăgeanu;J Med Life,2010

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological roles for resistin and related adipokines in obesity-associated tumors;International Immunopharmacology;2024-12

2. The role of interleukin‐6 family cytokines in cancer cachexia;The FEBS Journal;2024-07-08

3. Identification of adipokine-related gene-based molecular subtypes of colon cancer and prognostic characteristics;Colorectal Cancer;2024-06-21

4. PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25;Cell Biology International;2024-06-18

5. RBP7 functions as a tumor suppressor in HR + breast cancer by inhibiting the AKT/SREBP1 pathway and reducing fatty acid;Cancer Cell International;2024-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3